Cargando…

Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancer

OBJECTIVE: Immune checkpoint inhibitors have been widely used in the treatment of endometrial cancer (EC) with microsatellite instability-hypermutated (MSI-H). However, there is an unmet need for microsatellite stable (MSS) EC because of their modest activity. This study aimed to identify potential...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Jin Hwa, Cho, Hyun Woong, Ouh, Yung-Taek, Lee, Jae Kwan, Chun, Yikyeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995863/ https://www.ncbi.nlm.nih.gov/pubmed/36509464 http://dx.doi.org/10.3802/jgo.2023.34.e18

Ejemplares similares

Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset
por: Hong, Jin Hwa, et al.
Publicado: (2022)

Effects of hormone therapy on recurrence in endometrial cancer survivors: a nationwide study using the Korean Health Insurance Review and Assessment Service database
por: Cho, Hyun-Woong, et al.
Publicado: (2019)

Programmed death-1 (PD-1) expression in cervical intraepithelial neoplasia and its relationship with recurrence after conization
por: Chang, Hyeyoon, et al.
Publicado: (2018)

Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer
por: Stelloo, Ellen, et al.
Publicado: (2016)

Identification of a Subset of Microsatellite-Stable Endometrial Carcinoma with High PD-L1 and CD8+ Lymphocytes
por: Crumley, Suzanne, et al.
Publicado: (2018)

Long-term effect of pregnancy-related factors on the development of endometrial neoplasia: A nationwide retrospective cohort study
por: Cho, Hyun-Woong, et al.
Publicado: (2019)

Correction: Long-term effect of pregnancy-related factors on the development of endometrial neoplasia: A nationwide retrospective cohort study
por: Cho, Hyun-Woong, et al.
Publicado: (2019)

High Frequency Microsatellite Instability Has a Prognostic Value in Endometrial Endometrioid Adenocarcinoma, But Only in FIGO Stage 1 Cases
por: Steinbakk, Anita, et al.
Publicado: (2010)

Microsatellite instability and ploidy status define three categories with distinctive prognostic impact in endometrioid endometrial cancer
por: Bilbao-Sieyro, Cristina, et al.
Publicado: (2014)

L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma
por: Geels, Yvette P., et al.
Publicado: (2016)

EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
por: Alldredge, Jill K., et al.
Publicado: (2017)

Stage II endometrial cancer requires stratification according to uterine risk factor and sentinel lymph node sampling
por: Ouh, Yung-Taek, et al.
Publicado: (2020)

Hypoxia and Angiogenesis in Endometrioid Endometrial Carcinogenesis
por: Horrée, Nicole, et al.
Publicado: (2007)

VEGF Immunoexpression in Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

Snail Immunoexpression in Endometrioid Endometrial Carcinomas
por: FLORESCU, MIRELA MARINELA, et al.
Publicado: (2022)

Molecular characteristics of microsatellite stable early-onset colorectal cancer as predictors of prognosis and immunotherapeutic response
por: Lu, Can, et al.
Publicado: (2023)

CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas
por: NAKAYAMA, KENTARO, et al.
Publicado: (2015)

RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma
por: Liu, Shuang, et al.
Publicado: (2019)

Clinicopathological Prognostic Parameters of Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

Role of serum microRNAs as biomarkers for endometriosis, endometrioid carcinoma of ovary & endometrioid endometrial cancer
por: Kumari, Priti, et al.
Publicado: (2022)

Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
por: Kuai, Dan, et al.
Publicado: (2023)

CDK1 serves as a novel therapeutic target for endometrioid endometrial cancer
por: Ying, Xue, et al.
Publicado: (2021)

The expression of stanniocalcin-1, estrogen receptor and progesterone receptor in endometrioid endometrial cancer
por: Erkılınç, Gamze, et al.
Publicado: (2023)

Targeting Myeloid-Derived Suppressor Cell Trafficking as a Novel Immunotherapeutic Approach in Microsatellite Stable Colorectal Cancer
por: Johnson, Benny
Publicado: (2023)

Independent Tissue-Based Biomarkers in Endometrioid Endometrial Cancer: Tumor Budding in Microsatellite Instability and WHO Grading in Copy-Number-Low Patients
por: Stögbauer, Fabian, et al.
Publicado: (2023)

Long-term survival of endometrioid endometrial cancer patients
por: Gottwald, Leszek, et al.
Publicado: (2010)

Tumor grade and chemotherapy response in endometrioid endometrial cancer
por: Davidson, Brittany A., et al.
Publicado: (2016)

Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma
por: Yoneoka, Yutaka, et al.
Publicado: (2018)

An integrated prediction model of recurrence in endometrial endometrioid cancers
por: Miller, Marina D, et al.
Publicado: (2019)

Extragonadal Giant Endometrial Cyst with Endometrioid Borderline Tumor
por: Yazawa, Hiroyuki, et al.
Publicado: (2019)

Endothelin-3 is epigenetically silenced in endometrioid endometrial cancer
por: Zmarzły, Nikola, et al.
Publicado: (2022)

AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2021)

Proposal for cervical cancer screening in the era of HPV vaccination
por: Ouh, Yung-Taek, et al.
Publicado: (2018)

In reply: the evaluation of IgG titers' stability from blood samples is necessary
por: Ouh, Yung-Taek, et al.
Publicado: (2020)

UPF1 impacts on mTOR signaling pathway and autophagy in endometrioid endometrial carcinoma
por: Zhang, Minfen, et al.
Publicado: (2021)

Correlation of PD-L1 immunohistochemical expression with microsatellite instability and p53 status in endometrial carcinoma
por: Arafa, Mohammad, et al.
Publicado: (2022)

LAG‐3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeutics
por: Adashek, Jacob J., et al.
Publicado: (2023)

Comparison of Mirena and Liletta levonorgestrel intrauterine devices for the treatment of endometrial intraepithelial neoplasia and grade 1 endometrioid endometrial cancer
por: Chaudhari, Sonal R., et al.
Publicado: (2023)

Oncogenic c-terminal cyclin D1 (CCND1) mutations are enriched in endometrioid endometrial adenocarcinomas
por: Xu, Jia, et al.
Publicado: (2018)

An exploratory analysis of γ-synuclein expression in endometrioid endometrial cancer
por: Zou, Jing, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6vkdj4ual55lht59tlljpfk3fb